A DNA molecule is vulnerable to many types of DNAdamaging agents of both endogenous and exogenous origins. To date, the majority of DNA repair and mutagenesis studies are based on the actions of DNA polymerases during the replication process. The presence of DNA lesions interferes not only with replication but also with transcription. Therefore, to provide an accurate estimate risk of damaged DNA in living cells, it is an essential factor to understand the behavior of transcription elongation complexes on the transcribed strand containing DNA lesions, which are induced by mutagens and carcinogens in the environment. Notably, the vast majority of cells living outside the artiˆcial environment in growth factor-enriched media cannot continue to grow. Although such cells do not replicate their genome DNA, they only need to transcribe a large number of genes accurately to produce the necessary proteins for normal physiological processes. In this review, we describe the mechanism of RNA polymerases (RNAPs) stalled at DNA lesions, which is an implication of transcription-coupled nucleotide excision repair. The mutant transcripts derived from translesion RNA synthesis of RNAPs implicate the occurrence of transcriptional mutagenesis. The biological risks of DNA lesions induced by mutagens and carcinogens with regard to transcription elongation are discussed.
Introduction
DNA carrying genetic information has been continuously challenged by various exogenous and endogenous DNA-damaging agents. The DNA damage interferes with DNA replication, transcription and cell cycle progression, leading to mutations and cell death, which may also cause cancer, inborn diseases, and aging (1) (2) (3) .
A wide variety of DNA lesions, such as ultraviolet light (UV)-induced photolesions, intrastrand crosslinks, and bulky adducts induced by various carcinogens and mutagens, are eliminated by nucleotide excision repair (NER). NER is well conserved from bacteria to mammals, and consists of four consecutive steps: damage recognition, dual incisions on either side of the damage, excision of 24-32 oligonucleotides containing the damage, gapˆlling by repair DNA synthesis using the error-free strand as a template, and ligation (4) (5) (6) .
NER operates via two pathways: global genome repair (GGR) and transcription-coupled repair (TCR). GGR can act on the DNA lesions at any location in the whole genome, while TCR is clearly targeted to expressing genes, which depend on the cell condition or cell cycle, and is speciˆcally involved in removal of the lesions only on the transcribed strand and resumption of transcription (7) (8) (9) .
The biological importance of NER in humans has been suggested by studies on autosomal recessive human genetic disorders: xeroderma pigmentosum (XP) and Cockayne syndrome (CS), in which NER activity is impaired. XP patients are hypersensitive to sunlight and show increased incidence of UV-induced skin cancers. Although CS patients are sensitive to sunlight, they have no predisposition to sunlight-induced skin cancer, but instead show severe developmental and neurological abnormalities as well as premature aging. CS patients are speciˆcally deˆcient with regard to TCR, and it is thought that deˆciency of TCR leads to neurological damage in the brain (2, 7, 10) .
In TCR, blockage of RNA polymerase II (RNAPII) at the DNA damage site on the transcribed strand is thought to trigger this reaction and recruit other DNA repair factors to remove the transcription-blocking lesions. Thus, the blockage mechanism in TCR may be very important with regard to recognizing DNA lesions on the genome DNA. If DNA repair (probably transcription-coupled NER) does not occur to remove the transcription-blocking lesion, the stalling of RNAP continues. As a result, the cell cannot produce RNA transcripts. On the other hand, if the transcripts are essential, this may cause the cell to undergo apoptosis (9, (11) (12) (13) (14) . Transcriptional transition G to A, A to G, C to U, U to C Transcriptional transversion G to U, G to C, A to U, A to C, U to A, U to G, C to A, C to G Transcriptional frameshift ±(3n±1), where n is an integer Transcriptional mutation is a change in the sequence of a transcript. However, there are some cases of bypass wherein DNA lesions are bypassed to continue synthesizing the transcript (15) (16) (17) (18) . RNAP could bypass a lesion to produce the transcript. This process results in ribonucleotide misincorporation, which will generate mutant transcripts. When there is one transcriptional mutation in the termination codon of an mRNA transcript, the transcript may be subjected to nonsensemediated mRNA decay. However, in case there is no transcriptional mutation in the termination codon, the mutant transcript generated by damaged transcribed strands may be an important source of mutant proteins, particularly in non-dividing cells (heart muscle cell, nerve cell, etc.). This process is referred to as transcriptional mutagenesis (Table 1) . Therefore, DNA lesions on transcribed strands pose a major challenge to RNAP transcription.
This article will focus on the actions of RNAP, which function in the DNA lesion recognition step in TCR and the induction of transcriptional mutations by translesion RNA synthesis at speciˆc sites containing DNA lesions. In addition, we will discuss its biological risk in non-dividing living cells (Fig. 1) .
RNA Polymerases and Assays
There are some types of DNA-dependent RNA polymerases (RNAPs) and transcription elongation assays that can be used to investigate the behavior of RNAPs on the lesions.
Bacteriophage T7 and SP6 RNAPs are known to be one type of the simplest enzymes catalyzing RNA synthesis. T7 and SP6 RNAPs, single polypeptides of 98 kDa and 96 kDa, respectively, are capable of speciˆc initiation of transcription promoters, elongation with high processivity, and termination in the absence of additional factors. These enzymes are commercially available (19) . Therefore, they are useful to investigate the behavior of RNAPs on the DNA lesions on a transcribed strand. For the transcription elongation assay, we only need the enzyme, the template DNA containing the speciˆc promoter, and a DNA lesion at a deˆned position (20) (21) (22) .
E. coli RNAP is a relatively large molecule. The core complex consists ofˆve polypeptides (¿400 kDa). Since the core RNAP possesses the polymerase activity for elongation, elongation is performed for an oligo dCtailed template, which is promoter-less in order to observe transcription elongation. When another polypeptide (sigma factor) binds to the core complex, the RNAP can bind to the promoter-speciˆc regions. The sigma factor greatly reduces the a‹nity of RNAP for nonspeciˆc DNA, while it increases the speciˆcity for certain promoter regions. In this manner, transcription is initiated at the right region. Consequently, to investigate the action of RNAP on DNA lesions, the template DNA containing the speciˆc promoter and a DNA lesion at a deˆned position are required (23, 24) .
Although three kinds of RNAPs are found in eukaryotes, RNAPII is well employed because it transcribes protein-encoding genes into mRNA. RNAPII is a multimeric protein complex that consists of twelve polypeptides (¿600 kDa) (25, 26) . It transcribes DNA templates Fig. 2 . Transcription elongation assays to investigate the behavior of RNAPIIs on the lesions in eulkaryotic cells. Three assays are available for RNAPII. 1. Promoter-less assay is carried out with oligo dC-tailed template containing a DNA lesion on the transcribed strand and puriˆed RNAPII. 2. Promoter assay with adenovirus major late promoter (MLP) template containing a DNA lesion, puriˆed RNAPII, and puriˆed general transcription factors (TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH). 3. Promoter assay with MLP template containing a DNA lesion with HeLa cell nuclear extract which contains RNAPII, all general transcription factors, all DNA repair factors, and other factors.
as a complex, while its individual subunits have no such activity thus, it is impossible to predict``bonaˆde'' functions of an RNAPII from a single subunit. RNAPII is bound to the promoter regions of many or most developmental control genes with the help of transcriptional factors. Three assays are available for RNAPII.
(1) promoter-less assay with oligo dC-tailed template containing a DNA lesion and puriˆed RNAPII, (2) promoter assay with adenovirus major late promoter template containing DNA lesion, puriˆed RNAPII and puriˆed general transcription factors, and (3) promoter assay with adenovirus major late promoter template containing DNA lesion and HeLa cell nuclear extract which contains RNAPII, all general transcription factors, and DNA repair factors (27) (28) (29) (30) (Fig. 2) .
We do not anticipate that the promoter assay with cell extract is suitable to investigate the behavior of RNAPII on the damaged strand due to the presence of many factors that inhibit and eŠect of DNA repair and transcription elongation. For example, cyclobutane pyrimidine dimers (CPD) is a block-lesion for replication, and replication-type DNA polymerase is stalled at the lesion. However, in in vitro replication assay with cell extract, CPD is not bypassed by polymerase eta, but translesion DNA synthesis protein (XPV protein) is responsible. This might implicate that the cell extract system is not suitable to observe the action of RNAPII. In fact, in the case of investigating DNA synthesis on the DNA lesion, the primer extension assay is employed using puriˆed DNA polymerases and damaged templates (31, 32) .
RNAPII is a much more of a complex enzyme than other tested prokaryotic RNA polymerases. Thus, there are some variations in the action of RNAPs at the DNA lesions on the transcribed strand.
EŠects of DNA Lesions on RNAPs
Actions of RNAPs at DNA lesions on the transcribed strand were summarized in Table 2 .
AP sites: AP sites are the most frequent DNA base lesions in cells and are potentially genotoxic and mutagenic (1). These lesions are generated by spontaneous depurination at guanine at an estimated rate of 9000/day/genome in humans (33) . All RNAPs (phage RNAP, E.coli RNAP, and mammalian RNAPII) could insert nucleotide residues opposite AP sites without blocking. Hence, no transcriptional mutations were observed, indicating that no mutant proteins were generated through a bypass elongation reaction at the AP site. The mechanism of RNAPs inserting nucleotides opposite AP sites without any Watson-Crick pairing information is unknown as yet. However, considering the amount of AP sites produced in living cells, bypass transcription at the AP site might play a role in maintaining genome integrity. In case of replication-type DNA polymerases, it is known that AP sites completely block DNA synthesis because the absence of pairing information.
Uracil: Uracil in DNA is frequently generated by the deamination of cytosine in a pH-and temperaturedependent manner (1) . Uracil can pair with adenine without blocking DNA replication and therefore is very mutagenic. In fact, UDG-deˆcient E. coli shows a high frequency of spontaneous C to U transcriptional transitions. However, the present study indicates that in transcription, RNAPII inserts guanine and adenine opposite uracil without blocking transcription elongation. E. coli RNA polymerase also can insert guanine and adenine opposite lesions in vitro (24) . Thus, uracil in DNA would cause transcriptional inˆdelity and produce 
ND ND * T7 RNAP † SP6 RNAP Abbreviations: RNAP, RNA polymerase; TM, transcriptional mutagenesis (nucleotide inserted); del., deletion; CPD, cyclobutane pyrimidine dimer; (6-4)PP, (6-4) photoproduct; SSB, single-strand break; ND, not determined.
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Isao Kuraoka mutant proteins. In fact, it has been reported that the transcriptional bypass of uracil by E. coli RNAP results in the production of mutant proteins in vivo (34). These results suggest that uracil has to be removed before RNAPII meets the lesion to avoid the production of a mutant protein. In mammalian cells, four types of uracil DNA glycosylases exist to remove uracil lesions (3). Although the exact role of each of these uracil DNA glycosylases in cells is not known, it is likely that they remove uracil lesions on transcribed DNA and thus prevent transcriptional mutagenesis. Thymine glycol (Tg): It is reported that the average human cell repairs about 320 thymine glycol (Tg) sites/day based on the examination of the thymine to Tg content of urine (1) . Reactive oxygen species, ionizing radiation, and many other factors (UV irradiation, etc.) induce the oxidation of thymine to Tg. Tg is a strong blocking lesion for DNA polymerases in vitro (17, 35) and can be lethal in vivo (36) . There are many repair enzymes of the base excision repair system for Tg in a wide range of organisms. RNAPs stall at the lesions and cannot synthesize transcripts. Thus, no transcription mutagenesis is observed. Although the molecular mechanism of TCR is little known, the process is assumed to be initiated by the blockage of RNAPII at DNA lesions. Therefore, Tg might be one of the candidates repaired by transcription-coupled repair (17).
8-Oxoguanine (8-oxoG): Although many diŠerent lesions are formed in DNA after oxidative stress, 8-oxoguanine (8-oxoG) is one of the most abundant types of oxidative base damage and one of the most studied lesions. 8-OxoG in a syn conformation can form base pairs with adenine and induce G:C to T:A transversion mutations through DNA replication in vivo, indicating that the lesion does not block DNA polymerases (1). Phage RNAP and E.coli RNAP, like DNA polymerases, do not stall at the lesion. In case of RNAPII, both stalling and bypassing were observed. Bypassing the lesions, RNAPII, like DNA polymerase, inserted a cytosine residue or the incorrect adenine residue, leading to a G to U transcriptional transversion. This indicates that 8-oxoG lesions caused a blockage of tran-scription elongation and/or the misincorporation of a ribonucleotide, implying the initiation of transcriptioncoupled repair of 8-oxoG and/or transcriptional mutagenesis (15, 17, 33, 37) .
2-Hydroxyadenine (2-OH-A): 2-OH-A is also one of the most signiˆcant oxidative base lesions and a potentially mutagenic lesion. It is induced on template DNA by the misincorporation of 2-OH-dA generated by the oxidation of dATP, during DNA replication. 2-OH-A can form a base pair with guanine and induce G:C to T:A transversion (38, 39) . In the case of DNA polymerases, 2-OH-A is a minor blocking lesion to normal DNA synthesis. On the other hand, RNAPIIs completely stall at the lesion and synthesize no bypass transcripts. This indicates that 2-OH-A might be one of the candidates repaired by transcription-coupled repair. O 6 -Methylguanine (O 6 MeG): Various anti-cancer drugs, environmental mutagens and carcinogens alkylate DNA, inducing O 6 MeG, which provokes cell death by apoptosis (40) . O 6 MeG is repaired by O 6 -methylguanine-DNA methyltransferase (MGMT) and mismatch repair (MMR). Phage and E.coli RNAPs were able to bypass it, and transcriptional mutations were observed in transcripts, namely G to A transcriptional transition. On the other hand, RNAPIIs stall at the lesion, but sometimes bypass it under certain experimental conditions. RNAPII inserted a thymine residue or a cytosine residue opposite the lesions. It is well known that O 6 MeG induces apoptosis by the blockage of RNAPII due to binding of MMR proteins at O 6 MeG:T. However, in vitro data shows that RNAPII itself stalls at O 6 MeG without MMR proteins (24) . Cyclobutane pyrimidine dimers (CPD): CPD is the best-studied UV radiation-induced DNA lesion. It is repaired by NER eliminating a wide variety of bulky helix-distorting DNA lesions. CPD is a block-lesion for replication-type DNA polymerase. Nevertheless, translesion DNA polymerase eta can bypass it. All RNAPs (phage RNAP, E.coli RNAP, and mammalian RNAPII) stall at the lesions and cannot synthesize RNA transcripts beyond the lesions. It is well known that CPD is the best substrate for TCR due to the stalling of RNAPs, though CPD is not well repaired by GGR. Considering that there are no-transcripts produced by the lesions, transcriptional mutagenesis (TM) might have not occurred (27, 29, 41) .
6-4 Photoproduct (6-4PP): 6-4PP is more cytotoxic and mutagenic UV-induced DNA lesions than CPD, though it is less frequently produced. GGR repairs 6-4PPs more rapidly than CPDs. But TCR can repair CPDs and 6-4PPs at the same rate. In fact, both DNA lesions completely block RNA synthesis of RNAPs. This indicates that stalling of RNAPII at the damage site might be a trigger for TCR in human cells. Consequently, this suggests 6-4PP does do not produce TM. 6-4PP is converted to the Dewar isomer by UV-B irradiation (¿313 nm), which occurs in biological conditions (1) . Therefore, when the risk of Dewar lesions is estimated, it might be of considerable biological relevance (41, 42) .
Single-strand break (SSB): SSBs are the most frequent DNA lesions. They pose the most common threat to genetic stability and cell survival, by accelerating mutation rates and by increasing the levels of chromosomal aberrations. SSBs arise from the base excision repair processing of base damage indirectly. On the other hand, it may also arise directly from sugar damage induced by endogenous or exogenous agents. Phage and E.coli RNAPs bypass SSBs and induce transcriptional frameshift mutations. In the case of RNAPII, it stalls at SSBs, but there are no observations of transcriptional mutations. Occasionally, RNAPs are contemplated to stall at non-lesion sites under a certain experimental condition. Some of them might be due to undetectable SSBs on the transcribed strand (20) .
Gap: It is di‹cult toˆnd gap lesions in living cells, but after NER has removed a bulky lesion, gaps would be found. Interestingly, phage T7 RNAPs bypass gaps of various sizes on the transcribed strand, with the result that the transcripts have been internally deleted for the gapped region (22) . This might indicate the important role of non-transcribed and non-damaged strands during transcription elongation. So far, there are no observations in RNAPII.
EŠects of DNA Lesions in Non-dividing Cells
When the genotoxicity of DNA lesions in living cells is estimated, the laboratory cells are maintained in a favorable growth environment to promote viable replication by allowing cell cycle, DNA repair, apoptosis, and many aspects of cellular metabolism. However, a majority of cells in humans as well as other animals are not exposed to such experimental conditions. For example, non-dividing cells, like heart muscle cells and nerve cells (neurons), are terminally diŠerentiated, post-mitotic cells, yet are extremely active in transcription and translation, but not in replication. This suggests that transcription and translation events are more important research objects than replication events in such a situation. In addition, high-oxygen-consuming organs are composed of heart muscle cells and nerve cells. This indicates that DNAs in living cells are exposed to reactive oxygen species (ROS) and might be damaged (43) . Although the DNA lesions on transcription sites are not directly involved in genotoxicity, leading to mutations and cancers, the lesions block RNAP and lead to transcriptional mutations in RNA transcripts. Therefore, estimating the eŠects of DNA lesions on transcription might be essentially important to evaluate the causative eŠects of neurological dysfunction and aging, which mostly impacts the quality of life. In fact, studies of autosomal recessive human genetic disorders like XP and CS in which NER activity is impaired, suggests that the DNA repair mechanism is involved in neurological abnormalities of the brains, which consist of neurons and consume high amounts of oxygen (44) . In addition, ataxia telangiectasia (AT), Nijmegen breakage syndorome (NBS), and AT-like-disorder, in which doublestrand break (DSB) repair activity is impaired and neurological abnormalities are shown, also indicate the importance of the DNA repair mechanism and the risk of DNA lesions in the neurons (45) . DNA lesions would be bulky lesions removed by NER and strand breaks by DSB repair, which leads to a blockage of RNAP. These DNA lesions may pose as a high risk factor in nondividing cells. In addition, there is possibility that transcriptional mutagenesis by RNAP in non-dividing cells increase the number of mutant proteins or nonfunctional proteins. This is similar to normal mutagenesis by DNAP in dividing cells (Fig. 3) . The biological eŠects of DNA lesions on transcription may be thought of as a potent genotoxic and mutagenic threat in non-dividing cells.
